Personal information

Activities

Employment (4)

Freelance: Tel Aviv, IL

2022-02-01 to present | Scientific Consultant
Employment
Source: Self-asserted source
Paula Ofek

Medix Global: Tel Aviv, IL

2021-08-01 to present | Scientific Manager (Research Department)
Employment
Source: Self-asserted source
Paula Ofek

Tel Aviv University Sackler Faculty of Medicine: Tel Aviv, IL

2007-07-05 to 2021-07-31 | Research Associate (Department of physiology and Pharmacology)
Employment
Source: Self-asserted source
Paula Ofek

Prochon Biotech, Ltd: Nes Ziona, IL

1997-01-01 to 1999-12-31 | Research Assistant (Cell Signaling and Drug Discovery)
Employment
Source: Self-asserted source
Paula Ofek

Education and qualifications (4)

Weizmann Institute of Science Faculty of Biology: Rehovot, IL

2006-04-01 to 2007-07-01 | Posdoctoral Research Fellow (Department of Molecular Cell Biology)
Education
Source: Self-asserted source
Paula Ofek

Tel Aviv University: Tel Aviv, IL

2000-10-01 to 2005-07-01 | Ph.D. (Faculty of Life Sciences, Department of Cell Research and Immunology)
Education
Source: Self-asserted source
Paula Ofek

Hebrew University of Jerusalem: Jerusalem, Jerusalem, IL

1994-10-01 to 1996-07-01 | M.Sc. (Faculty of Medicine, Department of Physiology)
Education
Source: Self-asserted source
Paula Ofek

Hebrew University of Jerusalem: Jerusalem, Jerusalem, IL

1991-10-01 to 1994-07-01 | B.Sc. (Faculty of Life Sciences, Biology)
Education
Source: Self-asserted source
Paula Ofek

Works (27)

Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma

International Journal of Cancer
2023-08 | Journal article
Contributors: Paula Ofek; Eilam Yeini; Gali Arad; Artem Danilevsky; Sabina Pozzi; Christian Burgos Luna; Sahar Israeli Dangoor; Rachel Grossman; Zvi Ram; Noam Shomron et al.
Source: check_circle
Crossref

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.

JCI insight
2022-08-18 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Genomic alterations drive brain metastases formation in colorectal cancer: The role of IRS2

2022-06-12 | Preprint
Contributors: Inbal Greenberg; Ethan Sokol; Anat Klein Goldberg; Dor Simkin; Moshe Benhamou; Shai Bar-Shira; Michal Raz; Rachel Grossman; Eilam Yeini; Paula Ofek et al.
Source: check_circle
Crossref

Sulfonated Amphiphilic Poly(α)glutamate Amine—A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors

Pharmaceutics
2021-12-20 | Journal article
Contributors: Adva Krivitsky; Sabina Pozzi; Eilam Yeini; Sahar Israeli Dangoor; Tal Zur; Sapir Golan; Vadim Krivitsky; Nitzan Albeck; Evgeny Pisarevsky; Paula Ofek et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

Advanced Drug Delivery Reviews
2021-08 | Journal article
Contributors: Sabina Pozzi; Anna Scomparin; Sahar Israeli Dangoor; Daniel Rodriguez Ajamil; Paula Ofek; Lena Neufeld; Adva Krivitsky; Daniella Vaskovich-Koubi; Ron Kleiner; Pradip Dey et al.
Source: check_circle
Crossref

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.

Nature communications
2021-03-26 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek

Proteogenomics of glioblastoma associates molecular patterns with survival.

Cell reports
2021-03-01 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek

Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.

Journal of controlled release : official journal of the Controlled Release Society
2018-10-17 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek

Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2018-06-01 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek

Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.

Nature communications
2018-01-02 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek

Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.

Nanomedicine : nanotechnology, biology, and medicine
2017-11 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.

eLife
2017-10-04 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Angiogenesis regulation by nanocarriers bearing RNA interference.

Advanced drug delivery reviews
2017-02-02 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.

Nanomedicine : nanotechnology, biology, and medicine
2016-10 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.

Journal of controlled release : official journal of the Controlled Release Society
2016-08-26 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes.

ACS nano
2016-02-08 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Interfering cancer with polymeric siRNA nanomedicines.

Journal of biomedical nanotechnology
2014-01-01 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Administration, distribution, metabolism and elimination of polymer therapeutics.

Journal of controlled release : official journal of the Controlled Release Society
2012-07 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

Development of PEGylated doxorubicin-E-[c(RGDfK)<inf>2</inf>] conjugate for integrin-targeted cancer therapy

Polymers for Advanced Technologies
2011 | Journal article
EID:

2-s2.0-78650680393

Contributors: Polyak, D.; Ryppa, C.; Eldar-Boock, A.; Ofek, P.; Many, A.; Licha, K.; Kratz, F.; Satchi-Fainaro, R.
Source: Self-asserted source
Paula Ofek via Scopus - Elsevier

Rational design of multifunctional polymer therapeutics for cancer theranostics

Israel Journal of Chemistry
2010 | Journal article
EID:

2-s2.0-78649252035

Contributors: Ofek, P.; Miller, K.; Eldar-Boock, A.; Polyak, D.; Segal, E.; Satchi-Fainaro, R.
Source: Self-asserted source
Paula Ofek via Scopus - Elsevier

siRNA transfection by dendritic core-shell nanocarriers.

Journal of controlled release : official journal of the Controlled Release Society
2010 | Journal article
EID:

2-s2.0-79960574183

Contributors: Fischer, W.; Claderon, M.; Ofek, P.; Satchi-Fainaro, R.; Haag, R.
Source: Self-asserted source
Paula Ofek via Scopus - Elsevier

siRNA transfection by dendritic core-shell nanocarriers.

Journal of controlled release : official journal of the Controlled Release Society
2010-11 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2010-04-12 | Journal article
Contributors: Paula Ofek
Source: Self-asserted source
Paula Ofek
grade
Preferred source (of 2)‎

Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

PloS one
2009 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain.

Bioconjugate chemistry
2009-03 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central

An inducible system to study the growth arrest properties of protein phosphatase 2C.

Methods in enzymology
2003 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central
grade
Preferred source (of 2)‎

Cell cycle regulation and p53 activation by protein phosphatase 2C alpha.

The Journal of biological chemistry
2003-04 | Journal article
Source: Self-asserted source
Paula Ofek via Europe PubMed Central
grade
Preferred source (of 2)‎